Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| type B pancreatic cell | 3 studies | 43% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| pancreas | 3 studies | 24% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 256.52 | 328 / 328 | 70% | 36.56 | 125 / 178 |
| thymus | 73% | 18.78 | 478 / 653 | 18% | 2.14 | 110 / 605 |
| stomach | 75% | 19.69 | 271 / 359 | 2% | 0.24 | 7 / 286 |
| lung | 43% | 3.06 | 251 / 578 | 3% | 0.12 | 40 / 1155 |
| blood vessel | 23% | 1.42 | 301 / 1335 | 0% | 0 | 0 / 0 |
| brain | 16% | 0.84 | 432 / 2642 | 0% | 0 | 0 / 705 |
| intestine | 9% | 0.73 | 86 / 966 | 3% | 0.98 | 17 / 527 |
| uterus | 8% | 0.30 | 14 / 170 | 1% | 0.04 | 5 / 459 |
| heart | 9% | 0.45 | 80 / 861 | 0% | 0 | 0 / 0 |
| prostate | 8% | 0.36 | 19 / 245 | 0% | 0.01 | 2 / 502 |
| esophagus | 5% | 0.26 | 78 / 1445 | 1% | 0.22 | 2 / 183 |
| breast | 4% | 0.34 | 19 / 459 | 2% | 0.14 | 25 / 1118 |
| liver | 6% | 0.23 | 13 / 226 | 0% | 0.09 | 1 / 406 |
| ovary | 3% | 0.18 | 6 / 180 | 0% | 0.01 | 2 / 430 |
| spleen | 4% | 0.26 | 9 / 241 | 0% | 0 | 0 / 0 |
| adipose | 3% | 0.17 | 41 / 1204 | 0% | 0 | 0 / 0 |
| adrenal gland | 2% | 0.10 | 6 / 258 | 1% | 0.06 | 2 / 230 |
| skin | 1% | 0.03 | 15 / 1809 | 0% | 0 | 0 / 472 |
| muscle | 1% | 0.03 | 5 / 803 | 0% | 0 | 0 / 0 |
| bladder | 0% | 0 | 0 / 21 | 1% | 0.23 | 3 / 504 |
| peripheral blood | 1% | 0.02 | 5 / 929 | 0% | 0 | 0 / 0 |
| kidney | 0% | 0 | 0 / 89 | 0% | 0.00 | 2 / 901 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030322 | Biological process | stabilization of membrane potential |
| GO_0006813 | Biological process | potassium ion transport |
| GO_0071805 | Biological process | potassium ion transmembrane transport |
| GO_0034702 | Cellular component | monoatomic ion channel complex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005267 | Molecular function | potassium channel activity |
| GO_0022841 | Molecular function | potassium ion leak channel activity |
| GO_0015271 | Molecular function | outward rectifier potassium channel activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | KCNK16 |
| Protein name | Potassium two pore domain channel subfamily K member 16 Potassium channel subfamily K member 16 (2P domain potassium channel Talk-1) (TWIK-related alkaline pH-activated K(+) channel 1) (TALK-1) |
| Synonyms | TALK1 |
| Description | FUNCTION: Outward rectifying potassium channel. Produces rapidly activating and non-inactivating outward rectifier K(+) currents. |
| Accessions | ENST00000425054.6 [Q96T55-4] ENST00000373229.9 [Q96T55-1] ENST00000373227.8 [Q96T55-5] ENST00000507712.5 ENST00000437525.3 [Q96T55-3] D6RC57 Q96T55 |